Intrahepatic Blood Flow Occlusion and Cardiac Injury Risk in Partial Hepatectomy (NCT06753461) | Clinical Trial Compass
CompletedNot Applicable
Intrahepatic Blood Flow Occlusion and Cardiac Injury Risk in Partial Hepatectomy
2,600 participantsStarted 2014-11-28
Plain-language summary
The goal of this observational study is to examine whether intrahepatic blood flow occlusion strategies during partial hepatectomy are associated with postoperative cardiac injury in patients undergoing hepatectomy. The primary questions it seeks to address are:
1. Are the intrahepatic blood flow occlusion method, the number of occlusions, and the cumulative occlusion time associated with postoperative cardiac injury?
2. How do intrahepatic blood flow occlusion, intraoperative hypotension, and postoperative cardiac injury interact? Participants will contribute their inpatient medical records, including information on medical history, surgical procedures, and anesthesia details.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
. Lack of intraoperative hepatic portal occlusion data
. Insufficient perioperative myocardial injury biomarker measurement data
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study looked at whether blocking blood flow to the liver during partial liver removal raises the risk of heart muscle injury — does my planned liver surgery involve that same blood flow technique, and is my heart health a concern we should evaluate beforehand?
2Since this trial has already completed, has my doctor seen or reviewed any of its findings, and could those results change how my surgical team manages blood flow during my hepatectomy?
3The study was measuring something called myocardial injury after non-cardiac surgery, or MINS, which can happen even without obvious heart attack symptoms — what signs of MINS would my care team be watching for after my liver surgery, and how would it be treated if detected?
4Given that this research focused on both low blood pressure during surgery and the stress of restoring blood flow to the liver, are there steps my surgical team can take to reduce those specific risks based on what this study found?
5Are there alternative surgical approaches to partial liver removal that might carry a lower risk of heart stress, and is it worth discussing those options in light of what this completed study may have revealed?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Myocardial injury after non-cardiac surgery (MINS)